Sign in: Staff/Students
The University has been awarded more than £3m from the Engineering and Physical Sciences Research Council (EPSRC) for two research projects.
EPSRC is the main UK government agency for funding research and training in engineering and the physical sciences, investing more than £800 million a year in a broad range of subjects – from mathematics to materials science, and from information technology to structural engineering.
The grants, which have been awarded under EPSRC’s Healthcare Impact Partnerships scheme, will support two novel engineering and physical sciences projects that are aligned with healthcare and enable progression towards patient benefits in two highly important areas.
The first project, led by Professors Andrew Owen and Steve Rannard from the University’s Nanomedicine Partnership, is a collaboration between the University’s Department of Molecular and Clinical Pharmacology and the Department of Chemistry looking to progress novel materials and drug delivery through to adult human clinical trials.
The project seeks to validate a new polymeric material for drug delivery and improve the oral dosing of drugs through novel emulsion technologies. The approach is not limited to single drug class or disease and may impact large numbers of people with a variety of healthcare needs. The project has been awarded a grant worth £2,034,000.
The second project, led by Dr Victoria Kearns and Dr Tom McDonald, has been awarded a grant worth £1,050,000. This project is a collaboration between the University’s Department of Eye & Vision Science and Department of Chemistry looking to advance ophthalmic innovations, such as prolonged drug delivery to treat diseases of the back of the eye, to benefit a range of patients.
Professor Ken Badcock, Executive Pro Vice Chancellor for Science and Engineering, University of Liverpool, said: “This is an exciting time for research at the University of Liverpool. These projects build on our culture of innovation, strong community and outstanding facilities.
“These awards specifically recognise the strength and depth we already possess across our faculties of Science & Engineering and Health & Life Sciences, and will help further benefit the inter-disciplinary nature of our world-leading research.”
The Department of Molecular and Clinical Pharmacology is based in the University’s Institute of Translational Medicine, the Department of Eye and Vision Science is based in the University’s Institute of Ageing and Chronic Disease, and the Department of Chemistry is based in the University’s School of Physical Sciences.
To listen to Steve and Andrew’s podcast on nanomedicine please click here.
This grant does not cover the paediatric HIV therapy aspect of Professors Owen and Rannard’s work and the University is currently fundraising to support the advancement of this crucial project. For more details please visit: www.liverpool.ac.uk/giving/priorities/hiv
You must be logged in to post a comment.
All recent news
Breckenridge Chair of Clinical Pharmacology and Head of the Department of Pharmacology and Therapeutics appointed
Get ready for the start of term
14: Dame Louise Ellman and Professor William Hope
Play your part in #TeamLivUni
How we are safely welcoming live audiences back for Liverpool Literary Festival 2021
@LivUniPVCRI @livuniresthemes @livuninews https://twitter.com/N8research/status/1442490978804379655
Liverpool is leading a new global network to bring together animal & human #coronavirus research communities.
Funded by @UKRI partners include @APHAgovuk @roslininstitute @Pirbright_Inst @Cambridge_Uni
#OneHealth #LivUniCovid @ThePandemicInst @livuniHLS https://bit.ly/3AEEqHr
Preventing the next global pandemics depends on the collective capacity of universities. For @Wonkhe this morning I’ve written about Liverpool, Covid-19 and @ThePandemicInst, and what next: https://wonkhe.com/blogs/if-pandemics-are-predictable-could-they-be-preventable/